BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16635784)

  • 1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.
    Martin PJ; Weisdorf D; Przepiorka D; Hirschfeld S; Farrell A; Rizzo JD; Foley R; Socie G; Carter S; Couriel D; Schultz KR; Flowers ME; Filipovich AH; Saliba R; Vogelsang GB; Pavletic SZ; Lee SJ;
    Biol Blood Marrow Transplant; 2006 May; 12(5):491-505. PubMed ID: 16635784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
    Pavletic SZ; Martin P; Lee SJ; Mitchell S; Jacobsohn D; Cowen EW; Turner ML; Akpek G; Gilman A; McDonald G; Schubert M; Berger A; Bross P; Chien JW; Couriel D; Dunn JP; Fall-Dickson J; Farrell A; Flowers ME; Greinix H; Hirschfeld S; Gerber L; Kim S; Knobler R; Lachenbruch PA; Miller FW; Mittleman B; Papadopoulos E; Parsons SK; Przepiorka D; Robinson M; Ward M; Reeve B; Rider LG; Shulman H; Schultz KR; Weisdorf D; Vogelsang GB;
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):252-66. PubMed ID: 16503494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.
    Shulman HM; Kleiner D; Lee SJ; Morton T; Pavletic SZ; Farmer E; Moresi JM; Greenson J; Janin A; Martin PJ; McDonald G; Flowers ME; Turner M; Atkinson J; Lefkowitch J; Washington MK; Prieto VG; Kim SK; Argenyi Z; Diwan AH; Rashid A; Hiatt K; Couriel D; Schultz K; Hymes S; Vogelsang GB
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):31-47. PubMed ID: 16399567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.
    Pavletic SZ; Lee SJ; Socie G; Vogelsang G
    Bone Marrow Transplant; 2006 Nov; 38(10):645-51. PubMed ID: 16980994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
    Schultz KR; Miklos DB; Fowler D; Cooke K; Shizuru J; Zorn E; Holler E; Ferrara J; Shulman H; Lee SJ; Martin P; Filipovich AH; Flowers ME; Weisdorf D; Couriel D; Lachenbruch PA; Mittleman B; Vogelsang GB; Pavletic SZ
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):126-37. PubMed ID: 16443511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
    Jagasia MH; Greinix HT; Arora M; Williams KM; Wolff D; Cowen EW; Palmer J; Weisdorf D; Treister NS; Cheng GS; Kerr H; Stratton P; Duarte RF; McDonald GB; Inamoto Y; Vigorito A; Arai S; Datiles MB; Jacobsohn D; Heller T; Kitko CL; Mitchell SA; Martin PJ; Shulman H; Wu RS; Cutler CS; Vogelsang GB; Lee SJ; Pavletic SZ; Flowers ME
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):389-401.e1. PubMed ID: 25529383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.
    Paczesny S; Hakim FT; Pidala J; Cooke KR; Lathrop J; Griffith LM; Hansen J; Jagasia M; Miklos D; Pavletic S; Parkman R; Russek-Cohen E; Flowers ME; Lee S; Martin P; Vogelsang G; Walton M; Schultz KR
    Biol Blood Marrow Transplant; 2015 May; 21(5):780-92. PubMed ID: 25644957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
    Lee SJ; Wolff D; Kitko C; Koreth J; Inamoto Y; Jagasia M; Pidala J; Olivieri A; Martin PJ; Przepiorka D; Pusic I; Dignan F; Mitchell SA; Lawitschka A; Jacobsohn D; Hall AM; Flowers ME; Schultz KR; Vogelsang G; Pavletic S
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):984-99. PubMed ID: 25796139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.
    Pavletic SZ; Vogelsang GB; Lee SJ
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):387-8. PubMed ID: 25572033
    [No Abstract]   [Full Text] [Related]  

  • 10. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
    Filipovich AH; Weisdorf D; Pavletic S; Socie G; Wingard JR; Lee SJ; Martin P; Chien J; Przepiorka D; Couriel D; Cowen EW; Dinndorf P; Farrell A; Hartzman R; Henslee-Downey J; Jacobsohn D; McDonald G; Mittleman B; Rizzo JD; Robinson M; Schubert M; Schultz K; Shulman H; Turner M; Vogelsang G; Flowers ME
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):945-56. PubMed ID: 16338616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
    Couriel D; Carpenter PA; Cutler C; BolaƱos-Meade J; Treister NS; Gea-Banacloche J; Shaughnessy P; Hymes S; Kim S; Wayne AS; Chien JW; Neumann J; Mitchell S; Syrjala K; Moravec CK; Abramovitz L; Liebermann J; Berger A; Gerber L; Schubert M; Filipovich AH; Weisdorf D; Schubert MM; Shulman H; Schultz K; Mittelman B; Pavletic S; Vogelsang GB; Martin PJ; Lee SJ; Flowers ME
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):375-96. PubMed ID: 16545722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes for acute graft-versus-host disease prevention and treatment trials.
    Lee SJ; Williams LA
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):295-300. PubMed ID: 19747556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
    Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
    Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.
    Martin PJ; Lee SJ; Przepiorka D; Horowitz MM; Koreth J; Vogelsang GB; Walker I; Carpenter PA; Griffith LM; Akpek G; Mohty M; Wolff D; Pavletic SZ; Cutler CS
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1343-59. PubMed ID: 25985921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of methodological issues of clinical trials in multiple sclerosis.
    Montalban X
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive design of confirmatory trials: Advances and challenges.
    Lai TL; Lavori PW; Tsang KW
    Contemp Clin Trials; 2015 Nov; 45(Pt A):93-102. PubMed ID: 26079372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2018 update on chronic graft-versus-host disease].
    Inamoto Y
    Rinsho Ketsueki; 2018; 59(10):2300-2306. PubMed ID: 30305539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunosuppression compounds and experimental therapies for chronic graft-versus-host disease.
    Michael M; Shimoni A; Nagler A
    Acta Haematol; 2013; 130(1):34-43. PubMed ID: 23392110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.